tiprankstipranks
Sarepta price target raised to $185 from $139 at Evercore ISI
PremiumThe FlySarepta price target raised to $185 from $139 at Evercore ISI
27d ago
Sarepta price target raised to $200 from $170 at BMO Capital
PremiumThe Fly
Sarepta price target raised to $200 from $170 at BMO Capital
27d ago
Sarepta price target raised to $230 from $165 at Leerink
PremiumThe Fly
Sarepta price target raised to $230 from $165 at Leerink
27d ago
Sarepta price target raised to $235 from $166 at Needham
PremiumThe FlySarepta price target raised to $235 from $166 at Needham
30d ago
Sarepta price target raised to $223 from $215 at Goldman Sachs
PremiumThe Fly
Sarepta price target raised to $223 from $215 at Goldman Sachs
1M ago
Sarepta approval ‘home-run scenario,’ says Piper Sandler
PremiumThe Fly
Sarepta approval ‘home-run scenario,’ says Piper Sandler
1M ago
Sarepta price target raised to $226 from $185 at Barclays
PremiumThe FlySarepta price target raised to $226 from $185 at Barclays
1M ago
Sarepta Elevidys update ‘best-case scenario,’ says Morgan Stanley
PremiumThe Fly
Sarepta Elevidys update ‘best-case scenario,’ says Morgan Stanley
1M ago
Sarepta announces expanded FDA approval of Elevidys for DMD
PremiumThe Fly
Sarepta announces expanded FDA approval of Elevidys for DMD
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100